ModerateAtypical antipsychotic – dibenzodiazepine×Drugs for peptic ulcer and GORD. Proton pump inhibitors
Updated · Methodology
Mechanism
In the liver, CYP1A2 and CYP3A4 metabolise almost all of the clozapine, with some contribution from CYP2C19 and CYP2D6 (clozapine SmPC). Esomeprazole inhibits CYP2C19 and can raise the levels of drugs that this enzyme metabolises (esomeprazole SmPC). The clozapine SmPC, however, says the effect of CYP2C19 inhibition may be minimal. According to the US Food and Drug Administration (FDA) label, esomeprazole is not likely to inhibit CYP1A2, CYP2D6 or CYP3A4 (Nexium label, FDA). The clozapine SmPC names omeprazole as a CYP1A2 inducer. No document says this of esomeprazole, the S-isomer of omeprazole. Severe hypomagnesaemia has been reported after at least three months of proton pump inhibitor treatment (esomeprazole SmPC). During clozapine treatment, low magnesium raises the risk of QT prolongation (Clozaril label, FDA).
Symptoms
The documents describe no symptoms specific to this combination. If clozapine levels rise, seizures may occur, and their risk rises with the dose (Clozaril label, US Food and Drug Administration, FDA). During clozapine treatment, hypotension, bradycardia and fainting are more likely with rapid dose increases (Clozaril label, FDA). With long-term esomeprazole, hypomagnesaemia shows as fatigue, tetany, delirium, seizures, dizziness and ventricular arrhythmia (esomeprazole SmPC).
Management
No document contraindicates the combination or requires a dose change in advance. The clozapine SmPC recommends caution with any substance that inhibits or induces cytochrome P450 enzymes, and esomeprazole inhibits CYP2C19 (clozapine and esomeprazole SmPCs). According to the clozapine SmPC, a lower clozapine dose may be needed with inhibitors of cytochrome P450 enzymes to prevent adverse reactions. According to the esomeprazole SmPC, drugs metabolised by CYP2C19 may also need a lower dose. Adjust the clozapine dose individually and use the lowest effective dose (clozapine SmPC). If esomeprazole is prescribed long term, consider measuring magnesium before treatment and periodically during it (esomeprazole SmPC). Before starting clozapine, measure potassium and magnesium and correct electrolyte disturbances. Then check electrolytes periodically (Clozaril label, US Food and Drug Administration, FDA).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Esomeprazol (nº registro 63436), sección 4.5 (2025)– AEMPS, CIMA, nº registro 63436, sección 4.5
- AEMPS: Ficha técnica: Clozapina – Leponex (nº registro 59547), sección 4.5 (2026)– AEMPS, CIMA, nº registro 59547, revisión 06/2026, secciones 4.4 y 4.5
- FDA: Clozaril (clozapine) prescribing information (2025)– FDA, DailyMed, HLS Therapeutics, setid 90876802-0e3a-44c9-9ff7-1754dfbe736a, v21, 06/2025, sections 5.1, 5.4, 5.5, 7.1
- AEMPS: Ficha técnica: Clozapina (nº registro 59547), secciones 4.9 y 5.2 (2026)– AEMPS, CIMA, nº registro 59547 (Leponex 100 mg comprimidos, Viatris), revisión 06/2026, secciones 4.9 y 5.2
- AEMPS: Ficha técnica: Esomeprazol, Nexium Mups 20 mg (nº registro 63436), sección 4.4 (2025)– AEMPS, CIMA, nº registro 63436 (Nexium Mups 20 mg comprimidos gastrorresistentes, Grünenthal Pharma), revisión 09/2025, sección 4.4
- FDA: Nexium (esomeprazole magnesium) prescribing information (2025)– FDA, DailyMed, AstraZeneca Pharmaceuticals LP, setid f4853677-1622-4037-688b-fdf533a11d96, v74, 12/2025, sections 5.9, 7 and 12.3